Saba Capital increases GRX stake
Analysis based on 6 articles · First reported Aug 17, 2026 · Last updated Sep 08, 2026
The steady accumulation by a major shareholder signals confidence in the trust's value, potentially supporting the stock price near its 52-week high. The announced dividend provides a yield of 6.7%, which may attract income-focused investors.
Saba Capital Management, a major shareholder and director of Gabelli Healthcare & Wellness Trust (NYSE: GRX), has been steadily increasing its stake in the closed-end fund through a series of open-market purchases in August and September 2026. The transactions, disclosed in SEC filings, include purchases on August 11, 14, 19, and 21, and September 3, totaling over 33,000 shares at prices around $9.86 to $10.13 per share. Following these acquisitions, Saba Capital's beneficial ownership rose to over 2.15 million shares. The trust also announced a quarterly dividend of $0.17 per share, payable on September 23, 2026. Several other institutional investors, including Sit Investment Associates, Osaic Holdings, Fifth Third Bank, GAMCO Investors, Mario Gabelli, K2 Asset Management, Closed End Fund Advisors, and Private Advisor Group, also adjusted their positions in the trust during recent quarters.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard